SEC Form 4 · accession 0001140361-16-065198
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis W Sullivan
Director
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 11, 2016 | M | 9,969 | $8.43 | A | 38,469 | D | |
| Common StockF1,F2 | May 11, 2016 | S | 9,969 | $39.25 | D | 28,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F3 | $8.43 | May 11, 2016 | M | 9,969 | D | — | Jun 13, 2017 | Common Stock | 9,969 | 4,431 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on June 14, 2007.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.66, inclusive.
- F3The option vested in three equal installments in June 2008, 2009 and 2010.